Provided by Tiger Trade Technology Pte. Ltd.

iShares U.S. Healthcare ETF

70.64
-0.0392-0.06%
Post-market: 70.640.00000.00%16:15 EDT
Volume:465.45K
Turnover:32.86M
Market Cap:3.67B
PE:6.36
High:70.80
Open:70.61
Low:70.07
Close:70.68
52wk High:74.59
52wk Low:56.44
Shares:51.90M
Float Shares:51.90M
Volume Ratio:0.80
T/O Rate:0.90%
Dividend:0.80
Dividend Rate:1.13%
EPS(TTM):11.10
EPS(LYR):3.06
ROE:6.01%
ROA:0.87%
PB:1.31
PE(LYR):23.09

Loading ...

UnitedHealth Group Announces Earnings Release Date

THOMSON REUTERS
·
21 mins ago

Health Rounds: New Dye for MRI Exams Detects Lung Cancer Earlier

Reuters
·
1 hour ago

Thatch Raises $108 Million at $1 Billion Valuation

Reuters
·
3 hours ago

Thatch: Funding & Participation from the General Partnership, General Catalyst, Andreessen Horowitz, ADP Ventures, Eli Lilly & Others

THOMSON REUTERS
·
3 hours ago

LIVE Markets-from Ozempic Face to K-Beauty Factories: the Next Beauty Bet

Reuters
·
Yesterday

As Trump Backs Psychedelics Research, FDA Weighs Safety and Access Standards

Reuters
·
Yesterday

LIVE Markets-Autumn in New York: Factory Expansion Slows, Input Prices at Multi-Year Highs - Empire State

Reuters
·
Yesterday

Eli Lilly Stock (LLY) Gets New Buy Rating as Weight-Loss Drug Sales Accelerate

TIPRANKS
·
Yesterday

LIVE Markets-US Stock Indexes Swing Lower as Oil, Yields Jump

Reuters
·
Yesterday

Abbvie Exec Says Will Present Late-Stage Data for Blood Cancer Drug Etentamig at International Myeloma Society Meeting Later in September - Conf Call

THOMSON REUTERS
·
Yesterday

Abbvie Exec Says Existing Portfolio Provides 'Clear Line of Sight' to Very Strong Growth Well into Next Decade - Conf Call

THOMSON REUTERS
·
Yesterday

Abbvie Exec Says Apogee Fits 'Very Nicely' with Its Business Development Approach - Conf Call

THOMSON REUTERS
·
Yesterday

Abbvie Exec Says Plans to Start Enrolling Apogee's Zumilokibart This Year, Targets Launch in Early 2030 - Conf Call

THOMSON REUTERS
·
Yesterday

Abbvie Exec Says Tavapadon U.S. Launch Expected to Have 'Slower Burn' Due to Timing of Medicare Reimbursement - Conf Call

THOMSON REUTERS
·
Yesterday

Why One of the Last Eli Lilly Holdouts Just Upgraded the Stock to Buy

Dow Jones
·
Yesterday

Dow's Nearly 300-Point Fall Led by Losses in Johnson & Johnson, Nike Stocks

Dow Jones
·
Yesterday

U.S. Stocks on the MOVE-Eli Lilly, Waystar, Sysco

Reuters
·
Yesterday

Johnson & Johnson Says Subcutaneous Cancer Treatment Study Shows Low Rates Across Key Events, Discontinuation

MT Newswires Live
·
Yesterday

Testosterone Scripts for Women Rise, Along with Denials and Delays

Reuters
·
Yesterday

Berenberg Upgrades Eli Lilly and Co. to Buy From Hold, Adjusts Price Target to $1,400 From $1,220

MT Newswires Live
·
Yesterday